Singapore firm's shares jump as virus test get nod for EU sale

Shares of Biolidics Ltd. jumped on the Singapore Exchange as the Singapore-based medical device manufacturer said its rapid test kits for Covid-19 were approved for sale in the European Union.

SINGAPORE: Shares of Biolidics Ltd. jumped as the Singapore-based medical device manufacturer said its rapid test kits for Covid-19 were approved for sale in the European Union.

The stock rose as much as 12% in early trading after the firm announced on Monday that it received confirmation for CE marking on Friday. CE marking is a notification process to authorities which enables companies to market and sell products in the EU.